JNJ Stock Chart & Fundamental Analysis

Interactive Chart

About Johnson & Johnson

Name

Johnson & Johnson

CEO

Joaquin Duato

Website

www.jnj.com

Industry

Healthcare

Year Founded

1886

Employees

138,100

Johnson & Johnson is a healthcare company that develops medicines and medical technologies for use in clinical practice. Its model connects research, manufacturing, and patient access so therapies and devices move from trials to everyday care under consistent standards. Teams focus on areas where long-term treatment and careful procedure matter, pairing evidence with clear guidance for clinicians. Supply and quality systems favor steady availability over splashy launches, and education helps professionals apply products safely. Operations span many regions, but the promise is the same: dependable options that fit real care settings and can be supported for the long run. The emphasis is safety, labeling clarity, and continuity in daily use.

Analyst Ratings

Consensus Recommendation

Buy14

Hold8

Sell1

Fundamentals & Financials

Revenue (TTM)

$94.1B

Net Income (TTM)

$26.8B

EPS (TTM)

$11.1

ROA (TTM)

13.46%

Current Ratio

1.03

Dividend Yield

0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q4 2025	Q3 2025	Q2 2025
Revenue	$24,564M	$23,993M	$23,743M
Cost of Sales	$3,347M	$7,303M	$7,628M
Gross Profit	$21,217M	$16,690M	$16,115M
Operating Income	$5,391M	$7,096M	$6,810M
Net Income	$5,116M	$5,152M	$5,537M
EPS	$2.1	$2.14	$2.29

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Johnson & Johnson's Technical Indicators Summary

Johnson & Johnson is around $244.12 and exhibits a bullish technical profile with price above short, medium and long moving averages, including a comfortable distance from the 200‑day. Momentum indicators are positive—MACD and CCI show buying pressure—and RSI is firm without being overbought, while ADX reflects only modest trend strength. Volatility is moderate per ATR and on‑balance volume is supportive, which adds confirmation to the upward alignment. The classic pivot sits at $244.14 near the current level. Technical takeaway: bullish — multiple momentum measures and favorable moving‑average alignment support the positive stance.

Buy

14 signals

Neutral

8 signals

Sell

1 signal

Overall: Bullish61% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	59.87	Neutral	RSI (59.87) is neutral.
Stochastic %K (14, 3, 3)	82.53	Sell	Stochastic (82.53) > 80, indicating overbought.
CCI (20)	123.53	Buy	CCI (123.53) > 100, indicating strong upward momentum.
WPR (14)	-20.59	Neutral	Williams %R (-20.59) is neutral.
Momentum (10)	6.84	Buy	Momentum (6.84) is positive.
MFI	56.33	Neutral	MFI (56.33) is neutral.
MACD Level (12, 26)	0.91	Buy	Confirmed uptrend: MACD (0.91) is positive and above its signal line (0.68).
Bollinger Bands	$234.31 - $246.27	Neutral	Price is within the bands.
ATR (14)	$3.98 (1.63%)	Neutral	Moderate Volatility (1.63%).
ADX (14)	17.38	Neutral	Weak or consolidating trend (ADX < 25). ADX(17.38), +DI(25.56), -DI(17.64)
OBV	280,090,641	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(280,090,641), 20D-SMA-OBV(278,256,922)
Classic Pivot Point	$244.14	Neutral	Price ($244.12) hovering around equilibrium (P: $244.14) — no clear directional bias.
Fibonacci Pivot Point	$244.14	Neutral	Price ($244.12) hovering around equilibrium (P: $244.14) — no clear directional bias.
Simple Moving Averages	$197.97 - $240.29(5 indicators)	Buy	SMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$201.38 - $241.15(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The session wrapped with JNJ mildly under yesterday, as the -0.44% gap down left it closing around 243.04. The day closed with light sector weakness (-0.62%), providing a gentle headwind. JNJ drifts lower amid light sector weakness and a cautious market tone.

Price Change

from $243.03 close

-$0.07

Trading Volume

Below avg (8.1M)

5.2M

vs S&P 500 Today

Underperforming Market

-1.19%

52-Week Position

Near highs

92.1%